Incyte Announces EMA CHMP Positive Opinion Recommending Approval Of Opzelura Cream For Moderate Atopic Dermatitis; Application Now Referred To European Commission For Final Action

Loading news article.

Incyte Announces EMA CHMP Positive Opinion Recommending Approval Of Opzelura Cream For Moderate Atopic Dermatitis; Application Now Referred To European Commission For Final Action | WAPE

Incyte Announces EMA CHMP Positive Opinion Recommending Approval Of Opzelura Cream For Moderate Atopic Dermatitis; Application Now Referred To European Commission For Final Action

Article summary

Related companies

Comments —